Entrada Therapeutics Operating Margin Growth & History (TRDA)

Entrada Therapeutics's operating margin was −621.13% for fiscal 2025.

View full Entrada Therapeutics company overview

Entrada Therapeutics annual operating margin history

Entrada Therapeutics annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−621.13%−643.44 pp
20242024-12-3122.30%+24.75 pp
20232023-12-31−2.45%

Entrada Therapeutics operating margin trends

Across the available reported history, Entrada Therapeutics's operating margin decreased from 22.30% to −621.13%, a change of −643.44 percentage points. The latest reported quarter, Q2 2026, shows −5,007.02%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Entrada Therapeutics filings at SEC.gov ↗